About VLST Corporation
VLST Corporation was a Healthcare company based in Seattle (United States) founded in 2004 by Craig Smith. It develops monoclonal antibodies for treating conditions like multiple sclerosis and rheumatoid arthritis. It operates on a B2B model. VLST Corporation has raised $59.8 million across 2 funding rounds from investors including Amgen, TPG and Arch Venture Partners. Its website vlstcorp.com draws about 681 thousand monthly visits. The company is recorded as dissolved. Its focus areas include Biotechnology, Pharmaceuticals and Antibody Development. Its competitors include Biogen, Kymeratx and PureTech Health; 3 of its 3 listed competitors have raised funding.
Company details
VLST Corporation, established in 2004 and currently in Dissolved stage, focuses on providing healthcare solutions, advancing biotech innovations, producing pharmaceutical products, and antibody development. Develops monoclonal antibodies for treating conditions like multiple sclerosis and rheumatoid arthritis. Adapting to market demands with innovation and client-focused strategies.
- Headquarters Seattle, United States
- Founders Craig Smith
- SectorsHealthcare
- Website vlstcorp.com
- Total Equity Funding$59.8M (USD)
in 2 rounds
- Latest Funding Round$55M (USD), Series B
Jun 2006
- InvestorsAmgen
& 6 more
Funding Insights of VLST Corporation
VLST Corporation has successfully raised a total of $59.8M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $55 million completed in June 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $59.8M
- Total Rounds 2
- Last Round Series B — $55M
- First Round $4.8M
(Jun 2004)
- Investors Count 7
All 2 funding rounds of VLST Corporation with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2006 | $55M | Series B | – | – | |
| Jun 2004 | $4.8M | Series A | – | – |
7 investors in total: 7 institutional.
Investors in VLST Corporation
VLST Corporation has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Amgen, TPG and Arch Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Fund of funds focused on pre-seed and seed-stage companies | 1992 | tpg.com | Fort Worth, United States | |
Venture capital firm focused on life science companies | 1986 | archventure.com | Chicago, United States | |
| medimmuneventures.com | ||||
Early-stage venture capital is provided to US companies across sectors. | wrfseattle.org | Seattle, United States | ||
Venture capital services are offered for early-stage biotech companies. | acceleratorlsp.com | Seattle, United States | ||
Invests in biotech firms developing life-saving drugs and technologies. | mpmcapital.com | |||
Developer of pharmaceutical products for treating multiple diseases | 1980 | amgen.com | Thousand Oaks, United States |
Investor details for VLST Corporation
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of VLST Corporation
1 people are tracked at VLST Corporation (1 in leadership).
| Name | Role | Group |
|---|---|---|
Craig Smith | Founder | Leadership |
Complete people profiles for VLST Corporation
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of VLST Corporation
3 dated milestones of VLST Corporation across 2 years, from founding to its latest funding, stage changes and deals.
- Founded VLST Corporation is founded.
- Funding First funding round of $4.8M.
- Funding Latest funding round, Series B, of $55.0M.
Competitors of VLST Corporation
VLST Corporation has 3 listed competitors in our database, 3 of them funded. They include Biogen, Kymeratx and PureTech Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biogen.com | 1978 | Cambridge, United States | $80M | 1 | Therapies for neurodegenerative and immunology disorders are developed. | |
| kymeratx.com | 2016 | Cambridge, United States | $197M | 150 | Small molecule protein degraders are developed for various disorders. | |
| puretechhealth.com | 2001 | Boston, United States | $107M | 171 | Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases. |
Detailed competitors of VLST Corporation
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of VLST Corporation
The website of VLST Corporation (vlstcorp.com) receives about 680.7K visits a month.
- Monthly visits680.7K
▼ 6.7% vs previous month
Websites whose visitors overlap most with VLST Corporation. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| falconebiz.com | 100% | 959.8K | #63,970 | View details | |
| tofler.in | 97% | 556K | #105,509 | View details | |
| zaubacorp.com | 96% | 4.9M | #12,689 | View details | |
| tracxn.com | 92% | 2.9M | #16,597 | View details | |
| indiafilings.com | 90% | 2.1M | #29,959 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for VLST Corporation
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Immunology & Cancer Therapeutics
3 companies that operate in the same segment as VLST Corporation (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | |||
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vlst Corporation
Complete news archive for VLST Corporation
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VLST Corporation
VLST Corporation was founded in 2004.
VLST Corporation is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
VLST Corporation is a funded company, having raised a total of $59.8M across 2 funding rounds to date. The company's 1st funding round was a Series A of $4.8M, raised on Jun 2004.
VLST Corporation, established in 2004 and currently in Dissolved stage, focuses on providing healthcare solutions, advancing biotech innovations, producing pharmaceutical products, and antibody development. Develops monoclonal antibodies for treating conditions like multiple sclerosis and rheumatoid arthritis. Adapting to market demands with innovation and client-focused strategies.
VLST Corporation's top competitors include Kymeratx, PureTech Health and Biogen.
VLST Corporation has 7 investors. Key investors include Amgen, TPG, Arch Venture Partners, Turmeric Acquisition Corp, and MedImmune Ventures.
The website of VLST Corporation receives about 681 thousand visits a month.